Home / Companies / Fate Therapeutics, Inc. / 7 Jun 2024
Fate Therapeutics, Inc.: meeting of 7 Jun 2024
Votes reported on Form N-PX, item by item
289 Form N-PX filers reported votes at the Fate Therapeutics, Inc. meeting of 7 Jun 2024. Their records fall into 5 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
3 nominees; 90.4% of reported votes for; 23 filers withheld from or voted against at least one nominee.
574 vote records from 110 filers. 6 of the 110 filers that marked the item either way voted against management.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
403 vote records from 287 filers. 140 of the 274 filers that marked the item either way voted against management. 13 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
191 vote records from 109 filers. 2 of the 109 filers that marked the item either way voted against management.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
192 vote records from 110 filers. 61 of the 110 filers that marked the item either way voted against management.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
380 vote records from 108 filers. 13 of the 108 filers that marked the item either way voted against management.
How the largest families voted
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Fate Therapeutics, Inc. meeting?
289 Form N-PX filers reported votes at the meeting of 7 Jun 2024. On say-on-pay, 140 of 274 voted against management (51.1%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Fate Therapeutics, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Fate Therapeutics, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Fate Therapeutics, Inc. with a meeting date within three days of 7 Jun 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.